ANGPTL3 and ovarian carcinoma: However, recently, Wu et al. have shown that ANGPTL3 inhibition may have a negative impact on individuals with ovarian cancer, as ANGPTL3 is reduced in ovarian cancer tissues and cells, predicting a favorable prognosis.